Monoclonal Anti-Influenza A virus (Wisconsin/67/2022) Nucleopro

nfluenza A virus causes seasonal epidemics and poses a pandemic threat, necessitating robust diagnostic and research tools. The Nucleoprotein (NP) is a highly conserved and abundant viral protein, making it an excellent target for detecting various influenza A strains. This antibody is specifically developed against the Wisconsin/67/2022 strain, a relevant recent isolate. It serves as a crucial reagent for detecting viral NP in infected samples, supporting influenza research, diagnostic assay development, and vaccine efficacy studies by targeting a core viral component.